Lv1
56 积分 2024-08-07 加入
Tafasitamab as Monotherapy or in Combination in Japanese Patients With B‐Cell Non‐Hodgkin Lymphoma: Results From the Phase 1b J‐ MIND Study
21小时前
已完结
Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC)
9天前
已关闭
Injectable Minoxidil for Hair Loss Disorders: A Systematic Review
21天前
已完结
Tu1470 HZ-W084, A NOVEL VAV1 DEGRADER, ALLEVIATES DISEASE PROGRESSION IN PRE-CLINICAL MURINE COLITIS MODEL
2个月前
已完结
中国首次复发多发性骨髓瘤诊治指南（2026年版）
3个月前
已完结
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
5个月前
已完结
LB0008 SAP-001, A FIRST –IN-CLASS COMPOUND TARGETING A RENAL URATE TRANSPORTER, SHOWS POTENT SERUM URATE-LOWERING EFFECTS AND FAVORABLE SAFETY PROFILE IN A US PHASE 2b STUDY IN PATIENTS WITH REFRACTORY GOUT WITH OR WITHOUT PALPABLE TOPHI
8个月前
已完结
Semaglutide 2.4 mg in Participants With Metabolic Dysfunction‐Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial
9个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
9个月前
已完结
皖公网安备34019202002308
